Series Host and Moderator
Carol C. Cheung MD, PhD, JD, FRCPC
Carol Cheung is Deputy Director of Canadian Biomarker Quality Assurance.
For any questions about the Webinar series content, feel free to reach out to me at carol.cheung@cbqa.ca
Speakers
Carmela De Luca PhD, JD
Barrister and Solicitor
Patent Agent
Principal, Smart & Biggar LLP
Mary Kinloch MD, FRCPC
Saskatoon, Saskatchewan
Clinical Associate Professor, University of Saskatchewan
Dr. Kinloch is a practicing gynecologic pathologist and the Area Department Lead of Pathology and Laboratory Medicine in Saskatoon on Treaty 6 territory.
Provincially she sits as co-chairs for Biomarker Development and Quality Assurance Committee and Cervical Cancer Screening task force in Saskatchewan.
Nationally she is on the Board of Directors for the Canadian Association of Pathologists, the pathologist representative for CCTG’s EN.10 clinical trial, and internationally is on the International Association of Pathology’s Education Committee.
Her research interests include the effects of precision molecular classification of ovarian and endometrial cancer in the variation of oncologic treatment and bringing complete genomic profiling of ovarian cancer.
Emina Torlakovic MD, PhD, FCAP
Saskatoon, Saskatchewan
Founder and Director, Canadian Biomarker Quality Assurance
Head, Division of Hematopathology, Saskatchewan Health Authority
Professor, Pathology and Laboratory Medicine, University of Saskatchewan
Dr. Emina Emilia Torlakovic obtained her M.D. at the University of Zagreb Medical School and her Ph.D. at the University of Oslo Medical School. She is board certified by The American Board of Pathology in Anatomic and Clinical Pathology with subspecialty boards in Hematopathology. She is a professor at the Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan. She is a Division Head of Hematopathology, Saskatchewan Health Authority. She was a founding member of the NordiQC, has co-founded CIQC, and most recently founded Canadian Biomarker Quality Assurance (CBQA) as well as CBQAReadout.ca (inter)national academic quality assurance programs, which she is currently directing. Dr. Torlakovic is the Chair of the National Standards Committee for High Complexity Testing of the Canadian Association of Pathologists. She is the President of the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and a Board Member of the International Quality Network for Pathology (IQN Path). She is also currently leading several projects related to national and global standardization of clinical IHC applications.
Faculty Disclosure
Speakers and/or planning committee members will disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships within the last two (2) years with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
This intent is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts.
It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.